NEC OncoImmunity acquires Vaximm`s neoantigen vaccine development assets
09 Mar 2022 //
PHARMABIZ
NEC, VAXIMM to advance personalized neoantigen cancer vaccines
15 Nov 2019 //
BIOSPECTRUM ASIA
09 Mar 2022 //
PHARMABIZ
15 Nov 2019 //
BIOSPECTRUM ASIA